CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
May 2019—Roche and Spark Therapeutics entered into a definitive merger agreement for Roche to fully acquire Spark Therapeutics for about $4.3 billion.
Read More »May 2019—Roche and Spark Therapeutics entered into a definitive merger agreement for Roche to fully acquire Spark Therapeutics for about $4.3 billion.
Read More »